<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320576">
  <stage>Registered</stage>
  <submitdate>21/09/2010</submitdate>
  <approvaldate>6/10/2010</approvaldate>
  <actrnumber>ACTRN12610000843055</actrnumber>
  <trial_identification>
    <studytitle>Arterial stiffness in systemic inflammatory disease</studytitle>
    <scientifictitle>Arterial stiffness in systemic inflammatory disease
(observational case-control study)</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CRG050800138 (Cochrane Renal Group)</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>systemic inflammatory disease  ( e.g. systemic lupus erythematodes, periaortits )</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Autoimmune diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Evaluation of vascular risk markers in different study populations (cross-sectional case-control design) 
duration: 1 year
methods: arterial stiffness measured by pulse wave velocity; arterial blood pressure measured by spygnomanometry; evaluation of cardiovascular risk factors
(e.g. laboratory serum parameters like cholesterol, glycated hemiglobin and clinical assessment)</interventions>
    <comparator>None</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>arterial stiffness measured by pulse wave velocity</outcome>
      <timepoint>at time of recruitment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>-evaluation of cardiovascular risk factors
(e.g. laboratory serum parameters like cholesterol, glycated hemiglobin
tools: patient data information concering previous cardiovascular disease, smoking habits</outcome>
      <timepoint>at time of recruitment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>endothelial dysfunction
test e.g. serum markers ( Assymmetric dimethylarginine)</outcome>
      <timepoint>at time of recruitment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>arterial hypertension measured by automatic sphygnomanometry</outcome>
      <timepoint>at time of recruitment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>evaluation of cardiovascular risk factors 
(clinical assessment, medical tests)</outcome>
      <timepoint>at time of recruitment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- patients with active or chronic systemic inflammatory disease 

- or patients arterial hypertension for more than 5 years

- healthy persons

- written informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-    cardiac arrhythmia

-    patients / persons &lt; 18 years of age

-    women with a known pregancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>PD Dr. Eisenberger</primarysponsorname>
    <primarysponsoraddress>University Hopsital Bern
Freiburgstr. 10
3010 Bern</primarysponsoraddress>
    <primarysponsorcountry>Switzerland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>University Hospital Bern</fundingname>
      <fundingaddress>Department of Nephrology
Freiburgstr. 10
3010 Bern</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Evaluation of vascular risk markers in patients with systemic inflammation like patients with periaortitis or lupus in comparision to patients with and without arterial hypertension</summary>
    <trialwebsite />
    <publication>Previous work of our research group:

Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U. Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 2006;48(3):456-63</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>PD Dr, Ute, Eisenberger</name>
      <address>Senior resident, Nephrology and Hypertension, University Hospital Inselspital, Freiburgstrasse 10, CH-3010 Bern, Switzerland</address>
      <phone>+41 31 6323144</phone>
      <fax />
      <email>ute.eisenberger@insel.ch</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>PD Dr, Ute, Eisenberger</name>
      <address>Senior resident, Nephrology and Hypertension, University Hospital Inselspital, Freiburgstrasse 10, CH-3010 Bern, Switzerland</address>
      <phone>+41 31 6323144</phone>
      <fax />
      <email>ute.eisenberger@insel.ch</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>